APA (7th ed.) Citation

Fratino, L., Simonelli, C., Giacalone, A., Nigri, P., Sartor, I., Tartuferi, L., . . . Tirelli, U. (2008). Use of sorafenib in elderly patients (EP) affected by metastatic renal cell carcinoma (RCC) according to the Comprehensive Geriatric Assessment (CGA). Critical Reviews in Oncology/Hematology, 68, S46. https://doi.org/10.1016/S1040-8428(08)70106-9

Chicago Style (17th ed.) Citation

Fratino, L., et al. "Use of Sorafenib in Elderly Patients (EP) Affected by Metastatic Renal Cell Carcinoma (RCC) According to the Comprehensive Geriatric Assessment (CGA)." Critical Reviews in Oncology/Hematology 68 (2008): S46. https://doi.org/10.1016/S1040-8428(08)70106-9.

MLA (9th ed.) Citation

Fratino, L., et al. "Use of Sorafenib in Elderly Patients (EP) Affected by Metastatic Renal Cell Carcinoma (RCC) According to the Comprehensive Geriatric Assessment (CGA)." Critical Reviews in Oncology/Hematology, vol. 68, 2008, p. S46, https://doi.org/10.1016/S1040-8428(08)70106-9.